3Wurzer H,Schutze K,Bethket T,et al.Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen.Austrian Intravenous Pantoprazole study Group.Hepatogastroenterology,1999,46(27):1809
4Wright T A,Kingsnorth A N. High incidence of Hilicobacter pylori colonization of Barrett's oesophagus.Gut,1995,36:A38
5O'Connor H J,Cunnane K. Hilicobacter pylori and gastro-oesophageal reflux disease-a prospective study. Ir J Med Sci,1994,163(8):369
6Paull G,Yardley J H.Gastric and esophageal campylobacter pylori in patients with Barrett,soesophagus.Gastroenterology,1988,95(1):216
7Abbas Z,Hussainy A S,Ibrahim F. Barrett,soesophagus and Helicobacter pylori.J Gastroenteol Hepatol,1995,10(3):331
8Labenz J,Tillenburg B,Pettz U,et al.Helicobecter pylori augments the increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology,1996,110(3):725
9Holtmann G,Cain C,Melfertheiner P.Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.Gastroenterology,1999,117(1):11
10Kingkenberg-Knol EC,Festen HP,Jansen JB,et al.Long-term treatment with omeprazole for refractory reflux esophagitis :efficacy and safety.Ann Intern Med,1994,121(3):161
二级参考文献32
1El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998,43:327-333.
2Pera M,Cameron AJ,Trastek VF,et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 1993,104:510-513.
3Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett′s esophagus, Barrett′s dysplasia, and Barrett′s adenocarcinoma. Am J Gastroenterol,2000,95:387-394.
4Schenk BE, Kuipers EJ, Klinkenberg-Knol EC,et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. J Gastroenterol,1999,94:884-887.
5Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther,2000 ; 14: 427-432.
6Labenz J, Blum AL, Bayerdrffer E, et al. Curing helicobacter pylori infection in patints with duodenal ulcer may provoke reflux esophagitis. Gastroenterology,1997,112:1442-1447.
7Fallone CA,Barkun AN,Friedman G,et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease. Am J Gastroenterol,2000,95: 914-920.
8Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatus hernia and corpus gastritis. Aliment Pharmacol Ther, 2000,14:729-735.
9Tepes B, Kavcic B, Gubina M, et al. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. Hepatogastroenterology, 1999,46: 1746-1750.
10Feldman M,Cryer B,Sammer D,et al. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am J Physiol, 1999, 277(6 Pt 1):G1159-1164.
3DE MANZONI G,MORGAGNI P,ROVIELLO F,et al.Nodal abdominal spread in adenocarcinoma of the cardia.Results of a multicenter prospective study[J].Gastric Cancer,1998,1:146.
4SIEWERT JR,FEITH M,WERNER M,et al.Adenocarcuroma of the esophagogastric junction.Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients[J].Ann Surg,2000,232:353.
5FEITH M,STEIN HJ,SIEWERT JR.Pattern of lymphatic spread of Barrett's cancer[J].World J Surg,2003,27:052.
6BEUZEN F,DUBOIS S,FLEJOU JF.Chromosomal numerical aberrations are freguent in desophageal and gastric adenocarcinomas:A study using in-situ hybridization[J].Histopathology (Oxford),2000,37(3):241.
7TSELEPIS C,PERRY I,DAWSON C,et al.Tumor necrosis factoralpha in Barrett's esophagus:a potential novel mechanism of action[J].Oncogene,2002,21(39):6071.
8SPECHLER SJ,ROBBINS HB.Adenocarcinoma and Brarrett's esophagus[J].Anoverrated Risk Gastroenteroloy,1998,87:927.
9RANSFORD RA,JANKOWSKI JA.Genetic versus environmental interactions in the esophagUis-metaplasia-dysplasia-adenocarcinoma sequence (mcs) of Barrett's esophagus[J].Acta Gastroenterol Belg,2000,63(1):18.
10LIER MGF,BOMHOF FJ,LEENDERTSE I,et al.Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia[J].Clin Pathol,2005,58:722.
